Overview
60 Second Summary
Urinary incontinence (UI) is a common but often underreported condition affecting quality of life, confidence and daily functioning across all age groups. Pharmacists play an important role in recognising symptoms, supporting management and facilitating referral.
The main types of urinary incontinence include stress, urge, mixed, overflow and functional incontinence. Risk factors include ageing, obesity, pregnancy and childbirth, neurological disease, diabetes, mobility issues and certain medicines.
Assessment should include symptom history, medication review, contributing medical conditions and identification of referral triggers such as sudden onset symptoms, pain, haematuria or recurrent infections.
Conservative management remains first-line therapy for many patients and includes lifestyle measures, pelvic floor muscle training, bladder training and fluid, caffeine and weight management.
Pharmacological treatment is mainly used for urge incontinence/overactive bladder, with antimuscarinics and mirabegron representing key therapeutic options. Pharmacists should be mindful of adverse effects, anticholinergic burden and medication contributors such as diuretics and sedatives.
Continence products, skin care advice, sensitive communication and stigma reduction are also important aspects of pharmacy care. Through medicines optimisation, patient counselling and appropriate referral, pharmacists can make a significant contribution to improving continence outcomes and patient wellbeing.
Introduction:
Urinary incontinence (UI) is one of the most common conditions encountered in clinical practice, yet it remains significantly underreported and undertreated. While many patients assume urinary leakage is simply a consequence of ageing, pregnancy or chronic illness, urinary incontinence is not an inevitable part of growing older and, in many cases, can be effectively managed.
The condition affects millions of people worldwide and is associated with considerable physical, emotional and social consequences. Estimates suggest that up to one-third of people may experience urinary incontinence during their lifetime, with prevalence increasing among older adults, women following pregnancy and childbirth, and those living with chronic disease or mobility limitations.
However, the impact of urinary incontinence extends far beyond the bladder. Many patients restrict social activities, avoid exercise, limit travel and experience reduced confidence due to fear of leakage. Some may alter fluid intake inappropriately or delay seeking medical advice because of embarrassment or the mistaken belief that nothing can be done to help.
Community pharmacists are often among the most accessible healthcare professionals for patients experiencing urinary symptoms. Individuals may first present seeking continence products, advice on bladder symptoms or over-the-counter treatments. This places pharmacists in an important position to identify symptoms, recognise potential causes and facilitate timely referral where appropriate.
Understanding the Different Types of Urinary Incontinence
Urinary incontinence refers to the involuntary loss of urine, but it is not a single disease. Rather, it is a symptom that may arise from a variety of underlying mechanisms. Identifying the type of incontinence is important because management approaches differ depending on the cause.
Stress Urinary Incontinence
Stress urinary incontinence is one of the most common forms of urinary leakage, particularly among women. It occurs when increases in abdominal pressure exceed the ability of the urethra to remain closed, resulting in leakage during activities such as coughing, sneezing, laughing, lifting or exercise.
The condition is commonly associated with weakness of the pelvic floor muscles or reduced support of the bladder neck and urethra. Pregnancy, childbirth, obesity, menopause and advancing age are recognised risk factors. Men may also experience stress incontinence, particularly following prostate surgery.
Patients will often describe predictable leakage associated with physical activity rather than an overwhelming urge to pass urine.
Urge Urinary Incontinence
Urge urinary incontinence is characterised by a sudden and compelling need to urinate that is difficult to postpone, often resulting in leakage before the individual can reach a toilet.
Patients commonly report symptoms such as urgency, frequency and nocturia, alongside episodes of incontinence. Many describe feeling unable to control the urge once it occurs.
Urge incontinence is frequently associated with overactive bladder syndrome and may occur in the presence of urinary tract infections, diabetes, neurological disorders, cognitive impairment or medication-related effects.
Because symptoms can occur unpredictably, urge incontinence can have a particularly significant impact on quality of life, affecting sleep, work and social activities.
Mixed Urinary Incontinence
Many patients experience features of both stress and urge incontinence simultaneously. Mixed urinary incontinence is common, particularly among women, and may present as leakage during physical activity combined with episodes of urgency and inability to delay voiding.
Recognising mixed symptoms is important because treatment often requires a combination of interventions rather than a single management approach.
Overflow Incontinence
Overflow incontinence occurs when the bladder does not empty effectively, leading to overdistension and leakage. Patients may complain of a weak urinary stream, hesitancy, incomplete emptying, frequent dribbling or a sensation that the bladder never fully empties.
The condition is more commonly encountered in men and may be associated with bladder outlet obstruction caused by benign prostatic enlargement. Neurological conditions, severe constipation and certain medicines may also contribute.
Functional Incontinence
Functional incontinence differs from other forms because the bladder itself may function normally. Instead, the individual is unable to reach or use toilet facilities in time because of physical, cognitive or environmental barriers.
Reduced mobility, frailty, arthritis, dementia and environmental obstacles can all contribute. Functional causes are particularly relevant among older adults and those living in residential care settings.
Risk Factors and Contributing Factors
Urinary incontinence is rarely caused by a single factor. Instead, symptoms often develop through a combination of physiological, medical, lifestyle and medication-related influences.
Age remains one of the strongest risk factors, with prevalence increasing as people grow older. However, it is important to emphasise that incontinence should never be dismissed as a normal consequence of ageing. Older adults deserve the same level of assessment and intervention as any other patient presenting with urinary symptoms.
Obesity is another significant contributor, particularly in stress urinary incontinence. Increased abdominal pressure places additional strain on pelvic support structures and may worsen existing symptoms. Weight reduction has been shown to improve urinary symptoms in some individuals and should be considered as part of a broader management strategy where appropriate.
Pregnancy and childbirth also play an important role. Hormonal changes during pregnancy, combined with increased pressure on pelvic structures, can contribute to urinary leakage. Vaginal delivery is associated with a higher risk of pelvic floor injury and subsequent stress incontinence.
A range of chronic medical conditions may also influence bladder function. Diabetes mellitus, Parkinson’s disease, stroke, multiple sclerosis, spinal cord injury and dementia can all affect continence through neurological, functional or behavioural mechanisms.
Lifestyle factors can further exacerbate symptoms. Excessive caffeine intake, alcohol consumption, smoking-related chronic cough and constipation have all been associated with worsening urinary symptoms. While these factors are not usually the sole cause of incontinence, addressing them may improve symptom control.
Medicines and Urinary Symptoms
Medication review should form an essential part of any continence assessment.
A variety of medicines can contribute to urinary symptoms, either by precipitating new-onset incontinence or worsening existing problems. Because pharmacists routinely review prescriptions and over-the-counter purchases, they are uniquely placed to identify potential medication-related contributors.
Diuretics can increase urine production and contribute to urgency, frequency and nocturia. Sedatives and hypnotics may impair mobility or awareness, increasing the likelihood of accidents, particularly among older adults.
Certain antidepressants, anticholinergic medicines and antihistamines may influence bladder function, while medicines used in the management of neurological conditions can also affect urinary symptoms.
Pharmacists should be particularly alert when symptoms appear shortly after the initiation of a new medicine, following dose escalation or after significant changes to a patient’s medication regimen.
Assessment in Community Pharmacy
Although a definitive diagnosis may require medical assessment, pharmacists can play an important role in identifying symptom patterns and determining when referral is required.
A structured consultation can help distinguish between different types of incontinence and identify potential contributing factors. Useful assessment questions include:
- When did the symptoms begin?
- What circumstances trigger leakage?
- Is urgency present?
- Does the patient experience frequency or nocturia?
- Is there a sensation of incomplete emptying?
- Are there any relevant medical conditions or mobility issues?
- Could medicines be contributing?
- What measures have already been tried?
Understanding the patient’s experience is just as important as identifying the symptom pattern. Pharmacists should consider the impact on quality of life, including effects on sleep, confidence, work, exercise and social activities.
When to Refer
While many patients can initially be supported in the pharmacy setting, certain symptoms require prompt medical assessment.
Referral should be considered where patients present with:
- Sudden onset urinary symptoms
- Haematuria
- Pain or dysuria
- Suspected urinary tract infection
- Recurrent infections
- Significant urinary retention symptoms
- Neurological symptoms
- Rapid deterioration in symptoms
- Suspected medication-related complications
Persistent symptoms, diagnostic uncertainty or significant quality-of-life impairment should also prompt referral for further evaluation.
Early intervention is important. Urinary incontinence is frequently manageable, and community pharmacists can play a vital role in helping patients move from silent coping to appropriate treatment and support.
Non-Pharmacological Management: The Foundation of Care
For many patients, the management of urinary incontinence begins with conservative measures rather than medicines or surgical intervention. These approaches form the cornerstone of treatment across several continence conditions and are often recommended before pharmacological therapy is considered.
Community pharmacists can play a valuable role in supporting these interventions by reinforcing advice, encouraging adherence and helping patients understand that meaningful improvement may take time.
Lifestyle Modification
A number of lifestyle factors can influence urinary symptoms, and addressing these may lead to significant improvements for some patients.
Weight management is particularly relevant in stress urinary incontinence. Excess body weight increases intra-abdominal pressure, placing additional strain on the pelvic floor and bladder support structures. Even modest weight loss may reduce symptom severity and improve quality of life.
Dietary habits can also affect bladder function. Caffeine, found in coffee, tea, cola and energy drinks, may worsen urgency and frequency in susceptible individuals. Alcohol can have similar effects due to its diuretic properties. While complete avoidance is not always necessary, patients may benefit from monitoring whether symptom severity is linked to consumption patterns.
Hydration is another area where misconceptions are common. Many patients attempt to control symptoms by restricting fluid intake, sometimes excessively. However, inadequate hydration can result in concentrated urine, bladder irritation and worsening urinary symptoms. Pharmacists can provide balanced advice on maintaining appropriate fluid intake while avoiding excessive consumption.
Constipation should not be overlooked. Faecal loading can place pressure on the bladder, contribute to incomplete emptying and aggravate urinary symptoms. Addressing bowel health through dietary advice, hydration and medicines review may therefore form an important part of continence management.
Pelvic Floor Muscle Training
Pelvic floor muscle training remains one of the most effective first-line interventions for stress urinary incontinence and can also benefit some patients with mixed symptoms.
The pelvic floor muscles support the bladder, urethra and other pelvic organs. Weakness or dysfunction in these muscles may contribute to leakage during activities that increase abdominal pressure.
Pelvic floor exercises aim to strengthen these muscles through regular, structured contractions. Evidence consistently supports their use in stress urinary incontinence, particularly when patients receive appropriate instruction and maintain long-term adherence.
One of the challenges, however, is that many patients struggle to identify the correct muscles or perform the exercises effectively. Others become discouraged if improvement is not immediate.
Pharmacists can reinforce several important messages:
- Pelvic floor training requires consistency.
- Benefits may take several weeks or months to become apparent.
- Correct technique is essential.
- Ongoing practice is often needed to maintain results.
Referral to a physiotherapist specialising in pelvic health may be beneficial for patients requiring additional support.
Bladder Training
Bladder training is commonly recommended for urge urinary incontinence and overactive bladder symptoms.
The goal is to gradually increase the time between visits to the toilet and reduce urgency-driven voiding behaviour. Patients are encouraged to follow scheduled toileting routines, gradually extending the interval between voids while learning techniques to suppress urgency.
Symptom diaries can be particularly useful in helping patients identify patterns and track progress.
As with pelvic floor training, pharmacists should emphasise that bladder retraining is a gradual process and does not provide immediate results. Persistence and consistency are key to success.
Pharmacological Management
Drug therapy is primarily used in patients with urge urinary incontinence and overactive bladder symptoms. Pharmacological treatment is generally introduced alongside behavioural and lifestyle interventions rather than replacing them.
When counselling patients, pharmacists should discuss expected benefits, possible adverse effects and realistic timelines for improvement.
Antimuscarinic Medicines
Antimuscarinic agents remain widely used in the management of overactive bladder. These medicines work by reducing involuntary bladder muscle contractions, helping to improve bladder storage capacity and reduce symptoms of urgency, frequency and urge leakage.
Commonly prescribed agents include fesoterodine, solifenacin and darifenacin.
For many patients these medicines can provide meaningful symptom relief, but they are associated with a number of well-recognised adverse effects.
Dry mouth and constipation are particularly common and may affect adherence. Other possible side effects include dry eyes, blurred vision, dizziness and cognitive effects in susceptible individuals.
Older adults require special consideration. Many patients already receive medicines with anticholinergic properties for conditions such as allergies, depression, gastrointestinal disorders or Parkinson’s disease. The cumulative anticholinergic burden may increase the risk of adverse effects and should be reviewed carefully.
Pharmacists are ideally positioned to identify these risks through routine medicines review.
Mirabegron
Mirabegron offers an alternative treatment option for overactive bladder symptoms.
Unlike antimuscarinics, mirabegron acts through beta-3 adrenergic receptor stimulation, promoting relaxation of bladder smooth muscle during the storage phase of the micturition cycle.
Many patients find mirabegron attractive because it is associated with a lower incidence of dry mouth and constipation compared with antimuscarinic therapy.
As with all medicines, pharmacists should remain familiar with prescribing considerations, monitoring requirements and potential interactions.
Combination Therapy
Some patients may receive combination therapy when symptom control remains inadequate with a single agent. Counselling should focus on adherence, monitoring, management of side effects and the importance of regular review to assess effectiveness.
Medicines Optimisation: A Core Pharmacy Responsibility
Medicines review remains one of the pharmacist’s most valuable contributions to continence care.
Medication-related urinary symptoms are often overlooked, particularly in older adults receiving multiple medicines. Reviewing prescription histories, over-the-counter purchases and recent changes to treatment can reveal important contributors.
Diuretics may worsen urgency, frequency and nocturia by increasing urine production. Sedatives can impair mobility and awareness, increasing the risk of accidents. Medicines with anticholinergic properties may contribute to urinary retention or altered bladder function.
By identifying potential medicine-related causes, pharmacists can support safer prescribing and optimise overall management.
Continence Products: Supporting Dignity and Quality of Life
While continence products do not treat the underlying cause of urinary incontinence, they play an important role in symptom management and maintaining patient confidence.
Many patients use these products while awaiting assessment, during treatment initiation or as part of longer-term management plans.
Pads and liners are commonly used for light to moderate leakage and are available in a wide range of absorbencies and designs. Pull-up pants may be preferred by patients seeking greater discretion and independence, while higher-support products such as tab-fastened briefs may be required for individuals with severe symptoms, reduced mobility or caregiver support needs.
Selection should always be individualised. Factors such as leakage severity, mobility, dexterity, lifestyle, comfort and affordability all influence suitability.
Community pharmacists and pharmacy teams are frequently the first point of contact for patients seeking advice on product choice. Sensitive questioning can help ensure recommendations meet both clinical and practical needs.
Protecting Skin Health
One area that is often overlooked in continence management is skin integrity.
Repeated exposure to urine can increase the risk of irritation, dermatitis and infection.
Patients who regularly use absorbent products may benefit from advice on gentle cleansing, barrier protection and regular product changes.
Pharmacists should remain alert for signs of skin breakdown and recommend appropriate supportive care products when required.
Communication and Reducing Stigma
Urinary incontinence remains strongly associated with embarrassment and stigma. Many patients delay seeking help because they feel uncomfortable discussing symptoms or assume nothing can be done.
How pharmacists approach these conversations can have a significant impact on patient engagement.
Offering privacy where possible, using respectful language and normalising the discussion of continence concerns can help patients feel more comfortable disclosing symptoms.
Simple statements such as, “This is a very common condition,” or, “There are a number of effective treatment options available,” can help reduce anxiety and encourage help-seeking behaviour.
Pharmacists should avoid assumptions about who may be affected. Urinary incontinence can occur in younger adults, postpartum individuals, men following prostate surgery, people living with neurological disease and older adults alike.
Empathy and professionalism remain essential components of effective continence care.
Key Practice Points
Urinary incontinence is common, frequently underreported and often highly manageable. Accurate assessment of symptom patterns is essential to appropriate management, while medicines review should form a routine part of continence consultations.
Conservative interventions such as pelvic floor training, bladder retraining and lifestyle modification remain first-line approaches for many patients. Pharmacological treatment may provide additional benefit, particularly in urge urinary incontinence and overactive bladder.
Community pharmacists play an important role in identifying symptoms, recognising medicine-related contributors, supporting adherence, recommending appropriate continence products and facilitating referral when required.
Most importantly, pharmacists can help reduce the stigma surrounding urinary incontinence by creating a supportive environment in which patients feel comfortable seeking advice.
Conclusion
Urinary incontinence represents a significant but often hidden healthcare challenge. Although commonly associated with ageing, it affects people across the lifespan and may arise from a wide range of physiological, medical, neurological and medication-related causes.
For many patients, the impact extends far beyond physical symptoms, affecting confidence, independence, relationships and overall quality of life.
Community pharmacists occupy a uniquely valuable position within continence care. Through accessible consultations, medicines optimisation, product counselling and timely referral, pharmacists can support earlier recognition and more effective management of urinary symptoms.
Equally importantly, pharmacists can help challenge the stigma that continues to prevent many individuals from seeking support.
Continence care is not simply about managing leakage. It is about preserving dignity, supporting wellbeing and ensuring patients receive compassionate, evidence-informed care.
